Volker Gerdts
About
In The Last Decade
Volker Gerdts
152 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Immunology 1.6k
- Infectious Diseases 1.5k
- Epidemiology 1.4k
- Microbiology 977
- Molecular Biology 955
Countries citing papers authored by Volker Gerdts
This map shows the geographic impact of Volker Gerdts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Gerdts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Gerdts more than expected).
Fields of papers citing papers by Volker Gerdts
This network shows the impact of papers produced by Volker Gerdts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Gerdts. The network helps show where Volker Gerdts may publish in the future.
Co-authorship network of co-authors of Volker Gerdts
This figure shows the co-authorship network connecting the top 25 collaborators of Volker Gerdts. A scholar is included among the top collaborators of Volker Gerdts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Gerdts. Volker Gerdts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 50 | |
| 10 | 6 | |
| 11 | 14 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response. | 7 |
| 15 | 20 | |
| 16 | 31 | |
| 17 | 38 | |
| 18 | DNA-Impfstoffe in der Veterinärmedizin | 1 |
| 19 | 40 | |
| 20 | 44 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.